Proprotein convertase subtilisin kexin type 9 inhibitors: update from clinical trials to real-world experience
Publication
, Journal Article
Farnier, M
Published in: Current Opinion in Lipidology
December 2016
Duke Scholars
Published In
Current Opinion in Lipidology
DOI
EISSN
1473-6535
ISSN
0957-9672
Publication Date
December 2016
Volume
27
Issue
6
Start / End Page
597 / 604
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related Subject Headings
- Cardiovascular System & Hematology
- 3205 Medical biochemistry and metabolomics
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Farnier, M. (2016). Proprotein convertase subtilisin kexin type 9 inhibitors: update from clinical trials to real-world experience. Current Opinion in Lipidology, 27(6), 597–604. https://doi.org/10.1097/mol.0000000000000356
Farnier, Michel. “Proprotein convertase subtilisin kexin type 9 inhibitors: update from clinical trials to real-world experience.” Current Opinion in Lipidology 27, no. 6 (December 2016): 597–604. https://doi.org/10.1097/mol.0000000000000356.
Farnier M. Proprotein convertase subtilisin kexin type 9 inhibitors: update from clinical trials to real-world experience. Current Opinion in Lipidology. 2016 Dec;27(6):597–604.
Farnier, Michel. “Proprotein convertase subtilisin kexin type 9 inhibitors: update from clinical trials to real-world experience.” Current Opinion in Lipidology, vol. 27, no. 6, Ovid Technologies (Wolters Kluwer Health), Dec. 2016, pp. 597–604. Crossref, doi:10.1097/mol.0000000000000356.
Farnier M. Proprotein convertase subtilisin kexin type 9 inhibitors: update from clinical trials to real-world experience. Current Opinion in Lipidology. Ovid Technologies (Wolters Kluwer Health); 2016 Dec;27(6):597–604.
Published In
Current Opinion in Lipidology
DOI
EISSN
1473-6535
ISSN
0957-9672
Publication Date
December 2016
Volume
27
Issue
6
Start / End Page
597 / 604
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related Subject Headings
- Cardiovascular System & Hematology
- 3205 Medical biochemistry and metabolomics
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
- 1101 Medical Biochemistry and Metabolomics